Evaluation and Treatment of Rash
The appropriate evaluation and treatment of a rash requires proper classification based on clinical presentation, followed by targeted management according to the specific type and severity of the rash.1
Initial Evaluation
- Classify the rash based on morphology into one of four categories: petechial/purpuric, erythematous, maculopapular, or vesiculobullous 2
- Determine if the rash is associated with fever, which may indicate infectious causes such as roseola, erythema infectiosum, or scarlet fever 3
- Assess for pruritus, which commonly occurs with atopic dermatitis, pityriasis rosea, and tinea infections 3
- Evaluate distribution pattern, noting areas of involvement and sparing, particularly on palms, soles, face, and flexor/extensor surfaces 4
- Document onset, duration, and progression of the rash 5
- Identify potential triggers including medications, recent travel, environmental exposures, and contact with animals 5
Classification of Urticaria
Ordinary urticaria: Presents with spontaneous weals anywhere on the body with or without angio-oedema 1
- Acute: Up to 6 weeks of continuous activity
- Chronic: 6 weeks or more of continuous activity
- Episodic: Acute intermittent or recurrent activity
Physical urticarias: Reproducibly induced by specific physical stimuli 1
- Mechanical: Delayed pressure urticaria, symptomatic dermographism, vibratory angio-oedema
- Thermal: Cholinergic urticaria, cold contact urticaria, localized heat urticaria
- Other: Aquagenic urticaria, solar urticaria, exercise-induced anaphylaxis
Treatment Approach by Severity
Grade 1 Rash (Mild)
- Continue any ongoing treatments that may have caused the rash (such as EGFR-TKI therapy) 1
- Apply emollients regularly to affected areas 1
- For itchy rashes, apply mild topical corticosteroids such as hydrocortisone 1% cream to affected areas not more than 3-4 times daily 6
- Use gentle soaps and shampoos to avoid skin irritation 1
- If signs of superadded infection are present, apply topical antibiotics in alcohol-free formulations for at least 14 days 1
Grade 2 Rash (Moderate)
- Consider temporary interruption of causative medications if rash is prolonged or intolerable 1
- Intensify moisturizing regimen 1
- Apply medium-potency topical corticosteroids (e.g., clobetasone butyrate 0.05%) for 2-3 weeks 1
- Consider oral antihistamines for pruritus, though benefit may be limited 1
- For rashes covering 10-30% body surface area (BSA), consider oral prednisone at 0.5-1 mg/kg, tapering over 4 weeks 1
- Consider dermatology consultation if rash persists despite treatment 1
Grade 3 Rash (Severe)
- Temporarily interrupt any causative medications 1
- Apply high-potency topical corticosteroids (e.g., betamethasone valerate 0.1%) 1
- Initiate oral prednisone at 1 mg/kg/day, tapering over at least 4 weeks 1
- Consider oral antibiotics (e.g., tetracycline for ≥2 weeks) 1
- Refer to dermatologist for specialized management 1
- Resume causative medications only when rash has improved to grade ≤2 1
Grade 4 Rash (Life-threatening)
- Immediately discontinue causative medications 1
- Consider hospital admission with urgent dermatology consultation 1
- Administer systemic steroids: IV methylprednisolone 1-2 mg/kg with slow tapering when toxicity resolves 1
- Monitor closely for progression to severe cutaneous adverse reactions 1
- Consider alternative treatments rather than resuming medications that caused the severe reaction 1
Special Considerations
For drug-induced rashes:
For specific types of rash:
For occlusive dressing technique in recalcitrant conditions:
Common Pitfalls to Avoid
- Failing to consider the entire clinical presentation beyond just the appearance of the rash 3
- Using alcohol-containing gel formulations which can enhance skin dryness 1
- Prolonged use of sedative antihistamines, which may predispose to dementia (except in palliative care) 1
- Delaying referral to dermatology for severe or persistent rashes 1
- Neglecting to identify and appropriately treat superadded infections 1